UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis & rheumatology (Hoboken, N.J.), 2016-01, Vol.68 (1), p.1-26

2016

Volltextzugriff (PDF)

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

Arthritis care & research (2010), 2016-01, Vol.68 (1), p.1-25

2016

Volltextzugriff (PDF)

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

Seminars in arthritis and rheumatism, 2010-04, Vol.39 (5), p.327-346

Furst, Daniel E., MD

2010

Volltextzugriff (PDF)

Targeting inflammatory pathways in axial spondyloarthritis

Arthritis research & therapy, 2019-06, Vol.21 (1), p.135-135, Article 135

2019

Volltextzugriff (PDF)

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Arthritis & rheumatology (Hoboken, N.J.), 2016-02, Vol.68 (2), p.299-311

2016

Volltextzugriff (PDF)

Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis

Clinical therapeutics, 2004-12, Vol.26 (12), p.1960-1975

Furst, Daniel E.

2004

Volltextzugriff (PDF)

Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials

Rheumatology (Oxford, England), 2016-04, Vol.55 (4), p.669-679

2016

Volltextzugriff (PDF)

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials

Journal of rheumatology, 2010-03, Vol.37 (3), p.558-567

2010

Volltextzugriff (PDF)

Systemic sclerosis: hypothesis-driven treatment strategies

The Lancet (British edition), 2006-05, Vol.367 (9523), p.1683-1691

2006

Volltextzugriff (PDF)

Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review

Rheumatology (Oxford, England), 2017-07, Vol.56 (7), p.1177-1188

2017

Volltextzugriff (PDF)

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

Rheumatology (Oxford, England), 2014-09, Vol.53 (9), p.1560-1569

2014

Volltextzugriff (PDF)

Predicting treatment outcomes and responder subsets in scleroderma‐related interstitial lung disease

Arthritis & rheumatology (Hoboken, N.J.), 2011-09, Vol.63 (9), p.2797-2808

2011

Volltextzugriff (PDF)

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)

Journal of rheumatology, 2003-12, Vol.30 (12), p.2563

2003

Volltextzugriff (PDF)

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Arthritis and rheumatism, 2008-06, Vol.59 (6), p.762-784

2008

Volltextzugriff (PDF)

Biological agents in polyarticular juvenile idiopathic arthritis: a meta-analysis of randomized withdrawal trials

Seminars in arthritis and rheumatism, 2016-12, Vol.46 (3), p.312-318

2016

Volltextzugriff (PDF)

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis

Rheumatic & musculoskeletal diseases open, 2024-01, Vol.10 (1), p.e003423

2024

Volltextzugriff (PDF)

Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials

Seminars in arthritis and rheumatism, 2017-06, Vol.46 (6), p.699-708

2017

Volltextzugriff (PDF)

Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study

PloS one, 2015-09, Vol.10 (9), p.e0136982-e0136982

2015

Volltextzugriff (PDF)

Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients

Arthritis care & research (2010), 2012-12, Vol.64 (12), p.1811-1818

2012

Volltextzugriff (PDF)

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

Annals of the rheumatic diseases, 2015-01, Vol.74 (1), p.19-26

2015

Volltextzugriff (PDF)

The Rate of Adherence to Antiarthritis Medications and Associated Factors among Patients with Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis

Journal of rheumatology, 2016-03, Vol.43 (3), p.512-523

2016

Volltextzugriff (PDF)

Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis

Rheumatology (Oxford, England), 2013-10, Vol.52 (10), p.1809-1817

2013

Volltextzugriff (PDF)

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

Arthritis research & therapy, 2014-02, Vol.16 (1), p.R40-R40

2014

Volltextzugriff (PDF)

Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient

Rheumatic diseases clinics of North America, 2007-02, Vol.33 (1), p.197-217

2007

Volltextzugriff (PDF)

1 – 25 von 93

Suche als RSS-Feed

Aktive Filter

ThemaAntirheumatic Agents - Therapeutic Use

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(64)

Publikationsform

Artikel
(93)

Sprache

Englisch
(93)
Japanisch
(20)

Erscheinungsjahr

n.n

Thema

Humans
(93)
Science & Technology
(85)
Life Sciences & Biomedicine
(84)
Rheumatology
(83)
Arthritis, Rheumatoid - Drug Therapy
(62)
Male
(44)
Treatment Outcome
(44)
Female
(43)
Rheumatoid Arthritis
(43)
Middle Aged
(40)
Adult
(36)
Biological And Medical Sciences
(35)
Medical Sciences
(35)
Diseases Of The Osteoarticular System
(26)
Aged
(23)
Severity Of Illness Index
(23)
Methotrexate - Therapeutic Use
(22)
Inflammatory Joint Diseases
(21)
Drug Therapy, Combination
(20)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis

Targeting inflammatory pathways in axial spondyloarthritis

The American College of Rheumatology Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis

Anakinra: Review of recombinant human interleukin-I receptor antagonist in the treatment of rheumatoid arthritis

Efficacy and safety of biological agents for systemic juvenile idiopathic arthritis: a systematic review and meta-analysis of randomized trials

Longterm safety of patients receiving rituximab in rheumatoid arthritis clinical trials

Systemic sclerosis: hypothesis-driven treatment strategies

Examining the validity of the rheumatoid arthritis magnetic resonance imaging score according to the OMERACT filter-a systematic literature review

Rheumatoid arthritis pathophysiology: update on emerging cytokine and cytokine-associated cell targets

Predicting treatment outcomes and responder subsets in scleroderma‐related interstitial lung disease

Adalimumab, a fully human anti tumor necrosis factor-alpha monoclonal antibody, and concomitant standard antirheumatic therapy for the treatment of rheumatoid arthritis: results of STAR (Safety Trial of Adalimumab in Rheumatoid Arthritis)

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Biological agents in polyarticular juvenile idiopathic arthritis: a meta-analysis of randomized withdrawal trials

Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis

Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials

Most Trial Eligibility Criteria and Patient Baseline Characteristics Do Not Modify Treatment Effect in Trials Using Targeted Therapies for Rheumatoid Arthritis: A Meta-Epidemiological Study

Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of north america cohort of rheumatoid arthritis patients

Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period

2012 Update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis

The Rate of Adherence to Antiarthritis Medications and Associated Factors among Patients with Rheumatoid Arthritis: A Systematic Literature Review and Metaanalysis

Comorbidities are associated with poorer outcomes in community patients with rheumatoid arthritis

Clinical disease activity and acute phase reactant levels are discordant among patients with active rheumatoid arthritis: acute phase reactant levels contribute separately to predicting outcome at one year

Disease-modifying antirheumatic drug use in the elderly rheumatoid arthritis patient

Aktive Filter

Suchergebnisse filtern